Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 13/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 13/20 | 1.00 |
| ▸ | RAB9A | P51151 | 13/20 | 1.00 |
| ▸ | NPC1 | O15118 | 10/20 | 1.00 |
| ▸ | GAA | P10253 | 8/20 | 1.00 |
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | GLA | P06280 | 6/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 4/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | GFER | P55789 | 1/20 | 0.58 |
| ▸ | CDC7 | O00311 | 1/20 | 0.56 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.56 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.56 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5305847 | 0.85 | ALDH1A1 (0.76) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL3671367 | 0.85 | ALDH1A1 (1.00) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL1692157 | 0.84 | ALDH1A1 (1.00) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL9298339 | 0.84 | ALDH1A1 (0.73) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL14646388 | 0.84 | ALDH1A1 (0.73) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL1494735 | 0.84 | RAB9A (1.00) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL12970202 | 0.84 | ALDH1A1 (0.73) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL17626882 | 0.84 | ALDH1A1 (1.00) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL9560123 | 0.83 | ALDH1A1 (0.78) | ALDH1A1KDM4ERAB9ANPC1GAA | |
| SCHEMBL21705594 | 0.81 | RAB9A (0.73) | ALDH1A1KDM4ERAB9ANPC1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3638675-B1 | DIAZABICYCLIC SUBSTITUTED IMIDAZOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF BREATHING DISORDERS | BAYER AG (DE) | 2024-04-17 | — | — | EP | disclosed |
| US-20230329100-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20220017540-A1 | DIAZABICYCLIC SUBSTITUTED IMIDAZOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF BREATHING DISORDERS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-01-20 | — | — | US | disclosed |
| US-11208422-B2 | Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2021-12-28 | — | — | US | disclosed |
| US-20200140461-A1 | SUBSTITUTED BRIDGED DIAZEPANE DERIVATIVES AND USE THEREOF AS TASK-1 AND TASK-3 INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2020-05-07 | — | — | US | disclosed |
| EP-3638676-A1 | SUBSTITUTED BRIDGED DIAZEPANE DERIVATIVES AND USE THEREOF AS TASK-1 AND TASK-3 INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2020-04-22 | — | — | EP | disclosed |
| EP-2581365-B1 | Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode | SAMSUNG DISPLAY CO LTD (KR) | 2019-10-16 | — | — | EP | disclosed |
| WO-2018228909-A1 | SUBSTITUTED BRIDGED DIAZEPANE DERIVATIVES AND USE THEREOF AS TASK-1 AND TASK-3 INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-12-20 | — | — | WO | disclosed |
| US-9780313-B2 | Carbazole-based compound and organic light-emitting device including the same | SASMSUNG DISPLAY CO., LTD. (KR) | 2017-10-03 | — | — | US | disclosed |
| US-9780313-B2 | Carbazole-based compound and organic light-emitting device including the same | SASMSUNG DISPLAY CO., LTD. (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20100039029-A1 | Organic Light Emitting Diode Including Light-Efficiency-Improvement Layer | SAMSUNG DISPLAY CO., LTD. (KR) | 2010-02-18 | — | — | US | disclosed |
| US-20100039029-A1 | Organic Light Emitting Diode Including Light-Efficiency-Improvement Layer | SAMSUNG DISPLAY CO., LTD. (KR) | 2010-02-18 | — | — | US | disclosed |
| EP-1970376-B1 | Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same | SAMSUNG MOBILE DISPLAY CO LTD (KR) | 2009-11-18 | — | — | EP | disclosed |
| US-20090153035-A1 | Heteroaromatic cycle-containing compound, method of preparing the same and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090153035-A1 | Heteroaromatic cycle-containing compound, method of preparing the same and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090153035-A1 | Heteroaromatic cycle-containing compound, method of preparing the same and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-06-18 | — | — | US | disclosed |
| WO-2009070873-A1 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | MERCK FROSST CANADA LTD. (CA) | 2009-06-11 | — | — | WO | disclosed |
| US-20080226945-A1 | IMIDAZOPYRIMIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING ORGANIC LAYER INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2008-09-18 | — | — | US | disclosed |
| US-20080226945-A1 | IMIDAZOPYRIMIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING ORGANIC LAYER INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2008-09-18 | — | — | US | disclosed |
| EP-1970376-A1 | Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same | Samsung SDI Co., Ltd. (KR) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329100-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAT1, SLC1A2, SLC18A1 | ALDH1A1 121/4885KDM4E 897/4885RAB9A 2664/4885 |
| US-11208422-B2 | Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors | BET1, HRH1, GRIN1 | ALDH1A1 1483/4885KDM4E 1380/4885RAB9A 4077/4885 |
| US-20090153035-A1 | Heteroaromatic cycle-containing compound, method of preparing the same and organic light emitting device comprising the same | CCNE2, CCNC, CCNT1 | ALDH1A1 337/4885KDM4E 2044/4885RAB9A 3359/4885 |
| US-20200140461-A1 | SUBSTITUTED BRIDGED DIAZEPANE DERIVATIVES AND USE THEREOF AS TASK-1 AND TASK-3 INHIBITORS | GRIN1, BET1, HRH1 | ALDH1A1 1542/4885KDM4E 1415/4885RAB9A 4140/4885 |
| US-20220017540-A1 | DIAZABICYCLIC SUBSTITUTED IMIDAZOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF BREATHING DISORDERS | HIF1AN, QDPR, HNMT | ALDH1A1 645/4885KDM4E 2052/4885RAB9A 4465/4885 |
| US-20080226945-A1 | IMIDAZOPYRIMIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING ORGANIC LAYER INCLUDING THE SAME | TPMT, DPYD, TYMP | ALDH1A1 458/4885KDM4E 1056/4885RAB9A 3527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.